🎁 Black Friday: up to 50% off of annual plans
Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China flag China · Delayed Price · Currency is CNY
8.37
-0.43 (-4.89%)
Nov 20, 2026, 3:04 PM CST

SHE:300439 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
1,6541,5151,7281,8752,4732,238
Other Revenue
23.8523.8514.711.0116.3713.6
1,6781,5391,7421,8862,4892,252
Revenue Growth
14.04%-11.67%-7.61%-24.23%10.55%-2.19%
Cost of Revenue
1,113993.22972.721,0601,5521,348
Gross Profit
564.79545.94769.7825.44937.49903.98
Selling, General & Admin
372.64398.7403.11440.58475.15475.35
Research & Development
119.28127.2146.47149.8171.78150.68
Other Operating Expenses
14.29.24-0.788.3612.9417.5
Operating Expenses
509.47540.43529.07594.47700.85665.38
Operating Income
55.335.51240.63230.97236.63238.6
Interest Expense
-2.6-2.57-2.52-10.66-15.63-29.26
Interest & Investment Income
20.9612.624.8128.211.186.69
Currency Exchange Gain (Loss)
-0.31-0.31-2.56-0.644.34-2.9
Other Non Operating Income (Expenses)
-1.03-1.730.8527.01-13.24-3.67
EBT Excluding Unusual Items
72.3513.51261.21274.87223.27209.46
Impairment of Goodwill
------3.89
Gain (Loss) on Sale of Investments
-10.56-12.03-11.11-3.6-9.69-15.98
Gain (Loss) on Sale of Assets
1.691.66-0.67-0.78-0.320.48
Asset Writedown
0.78-0.3-2.2-10.87-13.1-0.13
Other Unusual Items
37.543.2535.1336.0623.1528.3
Pretax Income
101.7546.09282.36295.68223.31218.24
Income Tax Expense
0.23-15.2719.6936.1818.128.08
Earnings From Continuing Operations
101.5261.36262.67259.5205.2190.15
Minority Interest in Earnings
-1.011.84-4.68-2.95-6.68-10.66
Net Income
100.5163.2258256.55198.53179.49
Net Income to Common
100.5163.2258256.55198.53179.49
Net Income Growth
6.73%-75.50%0.56%29.23%10.61%-40.07%
Shares Outstanding (Basic)
395395385383382374
Shares Outstanding (Diluted)
395395385383382374
Shares Change
2.55%2.58%0.56%0.30%2.10%8.59%
EPS (Basic)
0.250.160.670.670.520.48
EPS (Diluted)
0.250.160.670.670.520.48
EPS Growth
4.08%-76.12%0%28.85%8.33%-44.81%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
19.3275.21-22.73353.16261.53313.67
Free Cash Flow Per Share
0.050.19-0.060.920.690.84
Dividend Per Share
0.0330.0330.1350.1340.1050.095
Dividend Growth
-75.56%-75.56%0.75%27.62%10.53%-39.38%
Gross Margin
33.66%35.47%44.17%43.77%37.66%40.15%
Operating Margin
3.30%0.36%13.81%12.25%9.51%10.60%
Profit Margin
5.99%4.11%14.81%13.60%7.98%7.97%
Free Cash Flow Margin
1.15%4.89%-1.30%18.73%10.51%13.93%
EBITDA
169.28153.86434.82383.73406.75412.01
EBITDA Margin
10.09%10.00%24.95%20.35%16.34%18.30%
D&A For EBITDA
113.96148.34194.19152.76170.12173.4
EBIT
55.335.51240.63230.97236.63238.6
EBIT Margin
3.30%0.36%13.81%12.25%9.51%10.60%
Effective Tax Rate
0.22%-6.97%12.24%8.11%12.87%
Revenue as Reported
1,6781,5391,7421,8862,4892,252